Since you have to do it why not do it right?   -  World class experts and Technology for new drug approval

----------

Pharsight, the maker of Phoenix® WinNonlin®, provides best-in-class PK/PD analysis, biostatistics 
and regulatory reporting services that are the backbone of every regulatory submission package. 
Equipped with Pharsight's own leading software and data management tools, we are your global partner 
for on-time, on-budget, on-target study analysis and reporting from preclinical through Phase IV.

Pharsight | 321 East Evelyn Avenue, 3rd Floor 
Mountain View, CA 94041-1530
Tel: 650.314.3800 | Fax: 650.314.3810


Website:
Pharsight Team Profile, Experience and Approach available at: Pharsight Online 
http://www.pharsight.com/services/ras_who.php

Data Sheet:
Benefits of Combining PK/PD Expertise and Technology for New Drug Approval
Download Capabilities Summary http://www.pharsight.com/library/Pharsight RAS_Data Sheet.pdf

Upcoming Event:
Turning PK/PD Data into Knowledge in Non-Clinical and Clinical Studies 
Featured Speaker: Jean-Francois Marier, PhD., FCP, Lead Scientist, Pharsight 
Register to Attend May 11 Oncology Biomarker Symposium - Montreal, Quebec 
http://www.pharsight.com/library/Pharsight RAS_Data Sheet.pdf

----------

:: A SERVICE ANNOUNCEMENT FROM APPLIED CLINICAL TRIALS ::


If you no longer wish to receive emails from Pharsight, 
Please email unsubscribe@certara.com with opy-out in the subject line.

ACT is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ 08830.
This is an advertisement sent on behalf of this advertiser.